Search

Your search keyword '"Seitz J"' showing total 1,453 results
Start Over Author "Seitz J"
1,453 results on '"Seitz J"'

1. Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia Nervosa.

Author

Walton, E, Hibar, D, Yilmaz, Z, Jahanshad, N, Cheung, J, Batury, V-L, Seitz, J, Bulik, C, Thompson, P, and Ehrlich, Stefan

Subjects
Anorexia nervosa, Brain structure, Genetic correlation, Anorexia Nervosa, Brain, Case-Control Studies, Genome-Wide Association Study, Humans, Linkage Disequilibrium, Magnetic Resonance Imaging, Mendelian Randomization Analysis, Organ Size, Polymorphism, Single Nucleotide
Abstract

In MRI scans of patients with anorexia nervosa (AN), reductions in brain volume are often apparent. However, it is unknown whether such brain abnormalities are influenced by genetic determinants that partially overlap with those underlying AN. Here, we used a battery of methods (LD score regression, genetic risk scores, sign test, SNP effect concordance analysis, and Mendelian randomization) to investigate the genetic covariation between subcortical brain volumes and risk for AN based on summary measures retrieved from genome-wide association studies of regional brain volumes (ENIGMA consortium, n = 13,170) and genetic risk for AN (PGC-ED consortium, n = 14,477). Genetic correlations ranged from - 0.10 to 0.23 (all p > 0.05). There were some signs of an inverse concordance between greater thalamus volume and risk for AN (permuted p = 0.009, 95% CI: [0.005, 0.017]). A genetic variant in the vicinity of ZW10, a gene involved in cell division, and neurotransmitter and immune system relevant genes, in particular DRD2, was significantly associated with AN only after conditioning on its association with caudate volume (pFDR = 0.025). Another genetic variant linked to LRRC4C, important in axonal and synaptic development, reached significance after conditioning on hippocampal volume (pFDR = 0.021). In this comprehensive set of analyses and based on the largest available sample sizes to date, there was weak evidence for associations between risk for AN and risk for abnormal subcortical brain volumes at a global level (that is, common variant genetic architecture), but suggestive evidence for effects of single genetic markers. Highly powered multimodal brain- and disorder-related genome-wide studies are needed to further dissect the shared genetic influences on brain structure and risk for AN.

Published
2019

3. Multicenter retrospective evaluation of a patient-tailored electrogram-based ablation strategy using an artificial intelligence software in repeat atrial fibrillation ablation procedures

Author

Figus, F, primary, Deisenhofer, I, additional, De Potter, T, additional, Smit, J J, additional, Busch, S, additional, Lepillier, A, additional, Lacotte, J, additional, Gitenay, E, additional, Monteau, J, additional, Ayari, A, additional, Martinez Lombard, E, additional, Siame, S, additional, Bars, C, additional, and Seitz, J, additional

Published
2024
Full Text
View/download PDF

8. Genetische Varianten in Genen der Kreatin-Biosynthese bei Patient*innen mit extremer Adipositas oder Anorexia nervosa

Author

Rajcsanyi, L. S., additional, Hoffmann, A., additional, Ghosh, A., additional, Matrisch-Dinkler, B., additional, Zheng, Y., additional, Peters, T., additional, Sun, W., additional, Dong, H., additional, Noé, F., additional, Wolfrum, C., additional, Herpertz-Dahlmann, B., additional, Seitz, J., additional, de Zwaan, M., additional, Herzog, W., additional, Ehrlich, S., additional, Zipfel, S., additional, Giel, K., additional, Egberts, K., additional, Burghardt, R., additional, Föcker, M., additional, Tsai, L., additional, Müller, T. D., additional, Blüher, M., additional, Hebebrand, J., additional, Hirtz, R., additional, and Hinney, A., additional

Published
2023
Full Text
View/download PDF

11. Single Proton Knock-Out Reactions from 24,25,26F

Author

Thoennessen, M., Baumann, R., Brown, B. A., Enders, J., Frank, N., Hansen, P. G., Heckman, P., Luther, B. A., Seitz, J., Stolz, A., and Tryggestad, E.

Subjects
Nuclear Experiment
Abstract

The cross sections of the single proton knock-out reactions from 24F, 25F, and 26F on a 12C target were measured at energies of about 50 MeV/nucleon. Ground state populations of 6.6+-.9 mb, 3.8+-0.6 mb for the reactions 12C(24F,23O) and 12C(25F,24O) were extracted, respectively. The data were compared to calculations based on the many-body shell model and the eikonal theory. In the reaction 12C(26F,25O) the particle instability of 25O was confirmed.

Published
2003
Full Text
View/download PDF

12. Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

Author

Azria, D., Doyen, J., Jarlier, M., Martel-Lafay, I., Hennequin, C., Etienne, P., Vendrely, V., François, E., de La Roche, G., Bouché, O., Mirabel, X., Denis, B., Mineur, L., Berdah, J., Mahé, M., Bécouarn, Y., Dupuis, O., Lledo, G., Seitz, J., Bedenne, L., Gourgou-Bourgade, S., Juzyna, B., Conroy, T., and Gérard, J.

Published
2017
Full Text
View/download PDF

17. The effects of polyunsaturated fatty acid (PUFA) administration on the microbiome-gut-brain axis in adolescents with anorexia nervosa (the MiGBAN study): study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial

Author

Keller, L., Dempfle, A., Dahmen, B., Schreiber, S., Adan, R.A.H., Andreani, N.A., Danner, U.N., Eisert, A., Fetissov, S., Fischmeister, F.Ph.S., Karwautz, A., Konrad, K., Kooij, K.L., Trinh, S., van der Vijgh, B., van Elburg, A.A., Zeiler, M., Baines, J., Seitz, J., Herpertz-Dahlmann, B., Trauma and Grief, Leerstoel Boelen, Leerstoel Engelhard, and Experimental psychopathology

Subjects
Clinical study, Inflammation, Gut microbiome, Supplementation, Medicine (miscellaneous), Polyunsaturated fatty acids, Pharmacology (medical), Anorexia nervosa, Gut microbiota, Microbiome-gut-brain axis, Gut permeability, RCT
Abstract

Background: Anorexia nervosa (AN) is a severe psychiatric disease that often takes a chronic course due to insufficient treatment options. Emerging evidence on the gut-brain axis offers the opportunity to find innovative treatments for patients with psychiatric disorders. The gut microbiome of patients with AN shows profound alterations that do not completely disappear after weight rehabilitation. In previous studies, the administration of polyunsaturated fatty acids (PUFA) resulted in effects that might be beneficial in the treatment of AN, affecting the microbiome, body weight and executive functions. Therefore, the MiGBAN study aims to examine the effects of a nutritional supplementation with PUFA on the gut microbiome and body mass index (BMI) in patients with AN. Methods: This is a longitudinal, double-blind, randomized, placebo-controlled trial. Within 2 years, 60 adolescent patients aged 12 to 19 years with AN will receive either PUFA or placebo for 6 months additional to treatment as usual. After 1 year, the long-term effect of PUFA on the gut microbiome and consecutively on BMI will be determined. Secondary outcomes include improvement of gastrointestinal symptoms, eating disorder psychopathology, and comorbidities. Additionally, the interaction of the gut microbiome with the brain (microbiome-gut-brain axis) will be studied by conducting MRI measurements to assess functional and morphological changes and neuropsychological assessments to describe cognitive functioning. Anti-inflammatory effects of PUFA in AN will be examined via serum inflammation and gut permeability markers. Our hypothesis is that PUFA administration will have positive effects on the gut microbiota and thus the treatment of AN by leading to a faster weight gain and a reduction of gastrointestinal problems and eating disorder psychopathology. Discussion: Due to previously heterogeneous results, a systematic and longitudinal investigation of the microbiome-gut-brain axis in AN is essential. The current trial aims to further analyse this promising research field to identify new, effective therapeutic tools that could help improve the treatment and quality of life of patients. If this trial is successful and PUFA supplementation contributes to beneficial microbiome changes and a better treatment outcome, their administration would be a readily applicable additional component of multimodal AN treatment. Trial registration: German Clinical Trials Register DRKS00017130. Registered on 12 November 2019.

Published
2022

23. The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa—: A study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial

Author

Gröbner, E.M., Zeiler, M., Fischmeister, F.Ph.S., Kollndorfer, K., Schmelz, S., Schneider, A., Haid-Stecher, N., Sevecke, K., Wagner, G., Keller, L., Adan, R., Danner, U.N., van Elburg, A.A., van der Vijgh, B., Kooij, K.L., Fetissov, S., Andreani, N.A., Baines, J.F., Dempfle, A., Seitz, J., Herpertz-Dahlmann, B., Karwautz, A., Gröbner, E.M., Zeiler, M., Fischmeister, F.Ph.S., Kollndorfer, K., Schmelz, S., Schneider, A., Haid-Stecher, N., Sevecke, K., Wagner, G., Keller, L., Adan, R., Danner, U.N., van Elburg, A.A., van der Vijgh, B., Kooij, K.L., Fetissov, S., Andreani, N.A., Baines, J.F., Dempfle, A., Seitz, J., Herpertz-Dahlmann, B., and Karwautz, A.

Abstract

Objective: Knowledge on gut–brain interaction might help to develop new therapies for patients with anorexia nervosa (AN), as severe starvation-induced changes of the microbiome (MI) do not normalise with weight gain. We examine the effects of probiotics supplementation on the gut MI in patients with AN. Method: This is a study protocol for a two-centre double-blind randomized-controlled trial comparing the clinical efficacy of multistrain probiotic administration in addition to treatment-as-usual compared to placebo in 60 patients with AN (13–19 years). Moreover, 60 sex- and age-matched healthy controls are included in order to record development-related changes. Assessments are conducted at baseline, discharge, 6 and 12 months after baseline. Assessments include measures of body mass index, psychopathology (including eating-disorder-related psychopathology, depression and anxiety), neuropsychological measures, serum and stool analyses. We hypothesise that probiotic administration will have positive effects on the gut microbiota and the treatment of AN by improvement of weight gain, gastrointestinal complaints and psychopathology, and reduction of inflammatory processes compared to placebo. Conclusions: If probiotics could help to normalise the MI composition, reduce inflammation and gastrointestinal discomfort and increase body weight, its administration would be a readily applicable additional component of multi-modal AN treatment.

Published
2022

24. The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa—: A study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial

Author

Trauma and Grief, Leerstoel Boelen, Leerstoel Engelhard, Experimental psychopathology, Gröbner, E.M., Zeiler, M., Fischmeister, F.Ph.S., Kollndorfer, K., Schmelz, S., Schneider, A., Haid-Stecher, N., Sevecke, K., Wagner, G., Keller, L., Adan, R., Danner, U.N., van Elburg, A.A., van der Vijgh, B., Kooij, K.L., Fetissov, S., Andreani, N.A., Baines, J.F., Dempfle, A., Seitz, J., Herpertz-Dahlmann, B., Karwautz, A., Trauma and Grief, Leerstoel Boelen, Leerstoel Engelhard, Experimental psychopathology, Gröbner, E.M., Zeiler, M., Fischmeister, F.Ph.S., Kollndorfer, K., Schmelz, S., Schneider, A., Haid-Stecher, N., Sevecke, K., Wagner, G., Keller, L., Adan, R., Danner, U.N., van Elburg, A.A., van der Vijgh, B., Kooij, K.L., Fetissov, S., Andreani, N.A., Baines, J.F., Dempfle, A., Seitz, J., Herpertz-Dahlmann, B., and Karwautz, A.

Published
2022

25. Pre- and postnatal antibiotic exposure and risk of developing attention deficit hyperactivity disorder-A systematic review and meta-analysis combining evidence from human and animal studies

Author

Otten, K., Keller, L., Puiu, A.A., Herpertz-Dahlmann, B., Seitz, J., Kohn, N., Edgar, J.C., Wagels, L., Konrad, K., Otten, K., Keller, L., Puiu, A.A., Herpertz-Dahlmann, B., Seitz, J., Kohn, N., Edgar, J.C., Wagels, L., and Konrad, K.

Abstract

Contains fulltext : 282639.pdf (Publisher’s version ) (Open Access), This study investigated the effects of early antibiotic exposure on ADHD risk by (1) integrating meta-analytical evidence from human observational studies examining the association between prenatal or early postnatal antibiotic exposure on the risk of developing ADHD; and (2) reviewing evidence from experimental animal studies on the effects of early antibiotic exposure on behavior. Sixteen human studies and five rodent studies were reviewed. A quantitative meta-analysis with 10 human studies indicated an increased risk for ADHD after prenatal antibiotic exposure (summary effect estimate Hazard Ratio (HR) 1.23, 95% CI 1.09-1.38; N = 2,398,475 subjects) but not after postnatal exposure within the first two years of life (summary effect estimate HR 1.12, 95% CI 0.95-1.32; N = 1,863,867 subjects). The rodent literature suggested that peri-natal antibiotic exposure has effects on social behavior, anxiety and aggression, alongside changes in gut microbial composition. Human and rodent findings thus suggest prenatal antibiotic exposure as a possible risk factor for ADHD, and suggest that an early disruption of the gut microbiome by antibiotics may interfere with neurodevelopment.

Published
2022

26. The effects of polyunsaturated fatty acid (PUFA) administration on the microbiome-gut-brain axis in adolescents with anorexia nervosa (the MiGBAN study): study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial

Author

Trauma and Grief, Leerstoel Boelen, Leerstoel Engelhard, Experimental psychopathology, Keller, L., Dempfle, A., Dahmen, B., Schreiber, S., Adan, R.A.H., Andreani, N.A., Danner, U.N., Eisert, A., Fetissov, S., Fischmeister, F.Ph.S., Karwautz, A., Konrad, K., Kooij, K.L., Trinh, S., van der Vijgh, B., van Elburg, A.A., Zeiler, M., Baines, J., Seitz, J., Herpertz-Dahlmann, B., Trauma and Grief, Leerstoel Boelen, Leerstoel Engelhard, Experimental psychopathology, Keller, L., Dempfle, A., Dahmen, B., Schreiber, S., Adan, R.A.H., Andreani, N.A., Danner, U.N., Eisert, A., Fetissov, S., Fischmeister, F.Ph.S., Karwautz, A., Konrad, K., Kooij, K.L., Trinh, S., van der Vijgh, B., van Elburg, A.A., Zeiler, M., Baines, J., Seitz, J., and Herpertz-Dahlmann, B.

Published
2022

36. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)†

Author

Aparicio, T., Lavau-Denes, S., Phelip, J. M., Maillard, E., Jouve, J. L., Gargot, D., Gasmi, M., Locher, C., Adhoute, X., Michel, P., Khemissa, F., Lecomte, T., Provençal, J., Breysacher, G., Legoux, J. L., Lepère, C., Charneau, J., Cretin, J., Chone, L., Azzedine, A., Bouché, O., Sobhani, I., Bedenne, L., Mitry, E., Amoyal, P., Auby, D., Bachet, J. B., Baconnier, M., Benoit, R., Berthelet, O., Bidault, A., Bineau, C., Bordes, G., Bouarioua, N., Boucher, E., Boulat, O., Cleau, D., Couzigou, P., Cuillerier, E., Cumin, I., Denis, B., Di Fiore, F., Derias, V., Ezenfis, J., Faroux, R., Gagnaire, A., Gatineau-Sailliant, G., Garcia, B., Genet, D., Gueye, A., Hammel, P., Lagasse, J. P., Landi, B., Lepage, C., Lobry, C., Lombard-Bohas, C., Mabro, M., Mackiewicz, R., Martin, J., Moncoucy, X., Morvan, F., Mozer, M., Pauwels, M., Petit-Laurent, F., Pouderoux, P., Prost, P., Queuniet, A. M., Ramdani, M., Rebischung, C., Rougier, P., Schnee, M., Seitz, J. F., Stefani, L, Taïeb, J., Terrebonne, E., Texereau, P., Thaury, J., Tougeron, D., Weber, A., Ricard, F., Bonnetain, F., Masskouri, F., Choine, C., Guiliani, F., Le Pessec, G., Fattouh, H., Le Provost, N., Girault, C., and Schneider, M.

Published
2016
Full Text
View/download PDF

39. Seeing through the Isolation: A Study of First-Year Teachers of the Visually Impaired.

Author

Seitz, J. A.

Abstract

This article presents results of a study of the first-year teaching experience of 103 teachers of students with visual impairments in Illinois. The study identified needs of beginning teachers and offered recommendations for universities and school districts to curb these teachers' high rate of attrition. (Author/DB)

Published
1994

45. Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis

Author

Blanc, J. (Jean-Frédéric) F. (F), Khemissa, F. (Faiza), Bronowicki, J. (Jean-Pierre) P. (P), Monterymard, C. (Carole), Perarnau, J. (Jean-Marc) M. (M), Bourgeois, V. (Vincent), Obled, S. (Stéphane), Abdelghani, M. (Meher) B. (Ben), Mabile-Archambeaud, I. (Isabelle), Faroux, R. (Roger), Seitz, J. (Jean-François) F. (F), Locher, C. (Christophe), Senellart, H. (Hélène), Villing, A. (Anne-Laure) L. (L), Audemar, F. (Franck), Costentin, C. (Charlotte), Deplanque, G. (Gaël), Manfredi, S. (Sylvain), Edeline, J. (Julien), and Habersetzer, F. (Francois)

Subjects
Sorafenib, medicine.medical_specialty, Cirrhosis, Population, Sciences du Vivant [q-bio]/Médecine humaine et pathologie, Gastroenterology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, Medicine, education, education.field_of_study, Hepatology, business.industry, medicine.disease, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 030211 gastroenterology & hepatology, business, Pravastatin, medicine.drug
Abstract

BACKGROUND AND AIMS: There is limited data regarding the role for systemic treatment in patients with Hepatocellular Carcinoma with Child-Pugh B cirrhosis. METHODS: PRODIGE 21 was a multicentric prospective non-comparative randomized trial. Patients were randomized to receive sorafenib (Arm A), pravastatin (Arm B), sorafenib-pravastatin (Arm C) combination, or best supportive care (Arm D). Primary endpoint was time to progression (TTP), secondary endpoints included safety and overall survival (OS). RESULTS: 160 patients were randomized and 157 patients were included in the final analysis. 86% of patients were BCLC C and 55% had macrovascular invasion. The safety profiles of the drugs were as expected. Median TTP was 3.5, 2.8, 2.0 and 2.2 months in arms A, B, C and D, respectively, but analysis was limited by the number of patients deceased without radiological progression (59%). Median OS was similar between the four arms: 3.8 [95% CI: 2.4-6.5], 3.1 [95% CI: 1.9-4.3], 4.0 [95% CI: 3.2-5.5] and 3.5 months [95% CI: 2.2-5.4] in arms A, B, C and D, respectively. Median OS was 4.0 months [95% CI: 3.3-5.5] for patients treated with sorafenib, vs 2.9 months [95% CI: 2.2-3.9] for patients not treated with sorafenib. In patients with ALBI grade 1/2, median OS was 6.1 months [95% CI: 3.8-8.3] in patients treated with sorafenib vs 3.1 months [95% CI: 1.9-4.8] for patients not treated with sorafenib. CONCLUSION: In the overall Child-Pugh B population, neither sorafenib nor pravastatin seemed to provide benefit. In the ALBI grade 1/2 sub-population, our trial suggests potential benefit of sorafenib. CLINICAL TRIAL REGISTRATION: The study was referenced in clinicaltrials.gov (NCT01357486).

Published
2021

46. Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies

Author

Munn-Chernoff, M.A. Johnson, E.C. Chou, Y.-L. Coleman, J.R.I. Thornton, L.M. Walters, R.K. Yilmaz, Z. Baker, J.H. Hübel, C. Gordon, S. Medland, S.E. Watson, H.J. Gaspar, H.A. Bryois, J. Hinney, A. Leppä, V.M. Mattheisen, M. Ripke, S. Yao, S. Giusti-Rodríguez, P. Hanscombe, K.B. Adan, R.A.H. Alfredsson, L. Ando, T. Andreassen, O.A. Berrettini, W.H. Boehm, I. Boni, C. Boraska Perica, V. Buehren, K. Burghardt, R. Cassina, M. Cichon, S. Clementi, M. Cone, R.D. Courtet, P. Crow, S. Crowley, J.J. Danner, U.N. Davis, O.S.P. de Zwaan, M. Dedoussis, G. Degortes, D. DeSocio, J.E. Dick, D.M. Dikeos, D. Dina, C. Dmitrzak-Weglarz, M. Docampo, E. Duncan, L.E. Egberts, K. Ehrlich, S. Escaramís, G. Esko, T. Estivill, X. Farmer, A. Favaro, A. Fernández-Aranda, F. Fichter, M.M. Fischer, K. Föcker, M. Foretova, L. Forstner, A.J. Forzan, M. Franklin, C.S. Gallinger, S. Giegling, I. Giuranna, J. Gonidakis, F. Gorwood, P. Gratacos Mayora, M. Guillaume, S. Guo, Y. Hakonarson, H. Hatzikotoulas, K. Hauser, J. Hebebrand, J. Helder, S.G. Herms, S. Herpertz-Dahlmann, B. Herzog, W. Huckins, L.M. Hudson, J.I. Imgart, H. Inoko, H. Janout, V. Jiménez-Murcia, S. Julià, A. Kalsi, G. Kaminská, D. Karhunen, L. Karwautz, A. Kas, M.J.H. Kennedy, J.L. Keski-Rahkonen, A. Kiezebrink, K. Kim, Y.-R. Klump, K.L. Knudsen, G.P.S. La Via, M.C. Le Hellard, S. Levitan, R.D. Li, D. Lilenfeld, L. Lin, B.D. Lissowska, J. Luykx, J. Magistretti, P.J. Maj, M. Mannik, K. Marsal, S. Marshall, C.R. Mattingsdal, M. McDevitt, S. McGuffin, P. Metspalu, A. Meulenbelt, I. Micali, N. Mitchell, K. Monteleone, A.M. Monteleone, P. Nacmias, B. Navratilova, M. Ntalla, I. O'Toole, J.K. Ophoff, R.A. Padyukov, L. Palotie, A. Pantel, J. Papezova, H. Pinto, D. Rabionet, R. Raevuori, A. Ramoz, N. Reichborn-Kjennerud, T. Ricca, V. Ripatti, S. Ritschel, F. Roberts, M. Rotondo, A. Rujescu, D. Rybakowski, F. Santonastaso, P. Scherag, A. Scherer, S.W. Schmidt, U. Schork, N.J. Schosser, A. Seitz, J. Slachtova, L. Slagboom, P.E. Slof-Op't Landt, M.C.T. Slopien, A. Sorbi, S. Świątkowska, B. Szatkiewicz, J.P. Tachmazidou, I. Tenconi, E. Tortorella, A. Tozzi, F. Treasure, J. Tsitsika, A. Tyszkiewicz-Nwafor, M. Tziouvas, K. van Elburg, A.A. van Furth, E.F. Wagner, G. Walton, E. Widen, E. Zeggini, E. Zerwas, S. Zipfel, S. Bergen, A.W. Boden, J.M. Brandt, H. Crawford, S. Halmi, K.A. Horwood, L.J. Johnson, C. Kaplan, A.S. Kaye, W.H. Mitchell, J. Olsen, C.M. Pearson, J.F. Pedersen, N.L. Strober, M. Werge, T. Whiteman, D.C. Woodside, D.B. Grove, J. Henders, A.K. Larsen, J.T. Parker, R. Petersen, L.V. Jordan, J. Kennedy, M.A. Birgegård, A. Lichtenstein, P. Norring, C. Landén, M. Mortensen, P.B. Polimanti, R. McClintick, J.N. Adkins, A.E. Aliev, F. Bacanu, S.-A. Batzler, A. Bertelsen, S. Biernacka, J.M. Bigdeli, T.B. Chen, L.-S. Clarke, T.-K. Degenhardt, F. Docherty, A.R. Edwards, A.C. Foo, J.C. Fox, L. Frank, J. Hack, L.M. Hartmann, A.M. Hartz, S.M. Heilmann-Heimbach, S. Hodgkinson, C. Hoffmann, P. Hottenga, J.-J. Konte, B. Lahti, J. Lahti-Pulkkinen, M. Lai, D. Ligthart, L. Loukola, A. Maher, B.S. Mbarek, H. McIntosh, A.M. McQueen, M.B. Meyers, J.L. Milaneschi, Y. Palviainen, T. Peterson, R.E. Ryu, E. Saccone, N.L. Salvatore, J.E. Sanchez-Roige, S. Schwandt, M. Sherva, R. Streit, F. Strohmaier, J. Thomas, N. Wang, J.-C. Webb, B.T. Wedow, R. Wetherill, L. Wills, A.G. Zhou, H. Boardman, J.D. Chen, D. Choi, D.-S. Copeland, W.E. Culverhouse, R.C. Dahmen, N. Degenhardt, L. Domingue, B.W. Frye, M.A. Gäebel, W. Hayward, C. Ising, M. Keyes, M. Kiefer, F. Koller, G. Kramer, J. Kuperman, S. Lucae, S. Lynskey, M.T. Maier, W. Mann, K. Männistö, S. Müller-Myhsok, B. Murray, A.D. Nurnberger, J.I. Preuss, U. Räikkönen, K. Reynolds, M.D. Ridinger, M. Scherbaum, N. Schuckit, M.A. Soyka, M. Treutlein, J. Witt, S.H. Wodarz, N. Zill, P. Adkins, D.E. Boomsma, D.I. Bierut, L.J. Brown, S.A. Bucholz, K.K. Costello, E.J. de Wit, H. Diazgranados, N. Eriksson, J.G. Farrer, L.A. Foroud, T.M. Gillespie, N.A. Goate, A.M. Goldman, D. Grucza, R.A. Hancock, D.B. Harris, K.M. Hesselbrock, V. Hewitt, J.K. Hopfer, C.J. Iacono, W.G. Johnson, E.O. Karpyak, V.M. Kendler, K.S. Kranzler, H.R. Krauter, K. Lind, P.A. McGue, M. MacKillop, J. Madden, P.A.F. Maes, H.H. Magnusson, P.K.E. Nelson, E.C. Nöthen, M.M. Palmer, A.A. Penninx, B.W.J.H. Porjesz, B. Rice, J.P. Rietschel, M. Riley, B.P. Rose, R.J. Shen, P.-H. Silberg, J. Stallings, M.C. Tarter, R.E. Vanyukov, M.M. Vrieze, S. Wall, T.L. Whitfield, J.B. Zhao, H. Neale, B.M. Wade, T.D. Heath, A.C. Montgomery, G.W. Martin, N.G. Sullivan, P.F. Kaprio, J. Breen, G. Gelernter, J. Edenberg, H.J. Bulik, C.M. Agrawal, A.

Subjects
mental disorders
Abstract

Eating disorders and substance use disorders frequently co-occur. Twin studies reveal shared genetic variance between liabilities to eating disorders and substance use, with the strongest associations between symptoms of bulimia nervosa and problem alcohol use (genetic correlation [rg], twin-based = 0.23-0.53). We estimated the genetic correlation between eating disorder and substance use and disorder phenotypes using data from genome-wide association studies (GWAS). Four eating disorder phenotypes (anorexia nervosa [AN], AN with binge eating, AN without binge eating, and a bulimia nervosa factor score), and eight substance-use-related phenotypes (drinks per week, alcohol use disorder [AUD], smoking initiation, current smoking, cigarettes per day, nicotine dependence, cannabis initiation, and cannabis use disorder) from eight studies were included. Significant genetic correlations were adjusted for variants associated with major depressive disorder and schizophrenia. Total study sample sizes per phenotype ranged from ~2400 to ~537 000 individuals. We used linkage disequilibrium score regression to calculate single nucleotide polymorphism-based genetic correlations between eating disorder- and substance-use-related phenotypes. Significant positive genetic associations emerged between AUD and AN (rg = 0.18; false discovery rate q = 0.0006), cannabis initiation and AN (rg = 0.23; q < 0.0001), and cannabis initiation and AN with binge eating (rg = 0.27; q = 0.0016). Conversely, significant negative genetic correlations were observed between three nondiagnostic smoking phenotypes (smoking initiation, current smoking, and cigarettes per day) and AN without binge eating (rgs = −0.19 to −0.23; qs < 0.04). The genetic correlation between AUD and AN was no longer significant after co-varying for major depressive disorder loci. The patterns of association between eating disorder- and substance-use-related phenotypes highlights the potentially complex and substance-specific relationships among these behaviors. © 2020 Society for the Study of Addiction

Published
2021

47. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

Author

Postema, M.C., Hoogman, M., Ambrosino, S., Asherson, P., Banaschewski, T., Bandeira, C.E., Baranov, A., Bau, C.H.D., Baumeister, S., Baur-Streubel, R., Bellgrove, Mark A., Biederman, J., Bralten, J.B., Brandeis, D., Brem, S., Buitelaar, J.K., Busatto, G.F., Castellanos, F.X., Cercignani, M., Chaim-Avancini, T.M., Chantiluke, K.C., Christakou, A., Coghill, D., Conzelmann, A., Cubillo, A.I., Cupertino, R.B., Zeeuw, P. de, Doyle, A.E., Durston, S., Earl, E.A., Epstein, J.N., Ethofer, T., Fair, D.A., Fallgatter, A.J., Faraone, S.V, Frodl, T., Gabel, M.C., Gogberashvili, T., Grevet, E.H., Haavik, J., Harrison, N.A., Hartman, Catharina A., Heslenfeld, D.J., Hoekstra, P.J., Hohmann, S., Høvik, M.F., Jernigan, T.L., Kardatzki, B., Karkashadze, G., Kelly, C., Kohls, G., Konrad, K., Kuntsi, J., Lazaro, L., Lera-Miguel, S., Lesch, K.P., Louza, M.R., Lundervold, A.J., Malpas, C.B., Mattos, P., McCarthy, H., Namazova-Baranova, L., Nicolau, R., Nigg, J.T., Novotny, S.E., Weiss, E. Oberwelland, Tuura, R.L. O'Gorman, Oosterlaan, J., Oranje, B., Paloyelis, Y., Pauli, P., Picon, F.A., Plessen, K.J., Ramos-Quiroga, J.A., Reif, A., Reneman, L., Rosa, P.G., Rubia, K., Schrantee, A., Schweren, L.J., Seitz, J., Shaw, P., Silk, T.J., Skokauskas, N., Vila, J.C. Soliva, Stevens, M.C., Sudre, G., Tamm, L., Tovar-Moll, F., Erp, T.G. van, Vance, A., Vilarroya, O., Vives-Gilabert, Y., Polier, G.G. von, Walitza, S., Yoncheva, Y.N., Zanetti, M.V., Ziegler, G.C., Glahn, D.C., Fisher, S.E., Franke, B., Francks, C., Postema, M.C., Hoogman, M., Ambrosino, S., Asherson, P., Banaschewski, T., Bandeira, C.E., Baranov, A., Bau, C.H.D., Baumeister, S., Baur-Streubel, R., Bellgrove, Mark A., Biederman, J., Bralten, J.B., Brandeis, D., Brem, S., Buitelaar, J.K., Busatto, G.F., Castellanos, F.X., Cercignani, M., Chaim-Avancini, T.M., Chantiluke, K.C., Christakou, A., Coghill, D., Conzelmann, A., Cubillo, A.I., Cupertino, R.B., Zeeuw, P. de, Doyle, A.E., Durston, S., Earl, E.A., Epstein, J.N., Ethofer, T., Fair, D.A., Fallgatter, A.J., Faraone, S.V, Frodl, T., Gabel, M.C., Gogberashvili, T., Grevet, E.H., Haavik, J., Harrison, N.A., Hartman, Catharina A., Heslenfeld, D.J., Hoekstra, P.J., Hohmann, S., Høvik, M.F., Jernigan, T.L., Kardatzki, B., Karkashadze, G., Kelly, C., Kohls, G., Konrad, K., Kuntsi, J., Lazaro, L., Lera-Miguel, S., Lesch, K.P., Louza, M.R., Lundervold, A.J., Malpas, C.B., Mattos, P., McCarthy, H., Namazova-Baranova, L., Nicolau, R., Nigg, J.T., Novotny, S.E., Weiss, E. Oberwelland, Tuura, R.L. O'Gorman, Oosterlaan, J., Oranje, B., Paloyelis, Y., Pauli, P., Picon, F.A., Plessen, K.J., Ramos-Quiroga, J.A., Reif, A., Reneman, L., Rosa, P.G., Rubia, K., Schrantee, A., Schweren, L.J., Seitz, J., Shaw, P., Silk, T.J., Skokauskas, N., Vila, J.C. Soliva, Stevens, M.C., Sudre, G., Tamm, L., Tovar-Moll, F., Erp, T.G. van, Vance, A., Vilarroya, O., Vives-Gilabert, Y., Polier, G.G. von, Walitza, S., Yoncheva, Y.N., Zanetti, M.V., Ziegler, G.C., Glahn, D.C., Fisher, S.E., Franke, B., and Francks, C.

Abstract

Item does not contain fulltext, OBJECTIVE: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. METHODS: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. RESULTS: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. CONCLUSION: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.

Published
2021

48. Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes

Author

Li, T, van Rooij, D, Roth Mota, N, Buitelaar, JK, Hoogman, M, Arias Vasquez, A, Franke, B, Ambrosino, S, Banaschewski, T, Bandeira, CE, Bau, CHD, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Bramati, IE, Brandeis, D, Berm, S, Busatto, GF, Calvo, A, Castellanos, FX, Cercignani, M, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Cupertino, RB, de Zeeuw, P, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fallgatter, AJ, Fair, DA, Faraone, SV, Frodl, T, Gabel, MC, Gogberashvili, T, Grevet, EH, Haavik, J, Harrison, NA, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Høvik, MF, Jahanshad, N, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lazaro, L, Lera-Miguel, S, Lesch, KP, Louza, MR, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Nicolau, R, Nigg, JT, O'Gorman Tuura, RL, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Picon, FA, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rosa, PGP, Rubia, K, Schrantee, A, Schweren, LJS, Seitz, J, Shaw, P, Silk, Tim, Skokauskas, N, Carlos Soliva Vila, J, Soloveva, A, Stevens, MC, Sudre, G, Tamm, L, Thompson, PM, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, Yoncheva, YN, Zanetti, MV, Ziegler, GC, Anikin, A, Asherson, P, Li, T, van Rooij, D, Roth Mota, N, Buitelaar, JK, Hoogman, M, Arias Vasquez, A, Franke, B, Ambrosino, S, Banaschewski, T, Bandeira, CE, Bau, CHD, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Bramati, IE, Brandeis, D, Berm, S, Busatto, GF, Calvo, A, Castellanos, FX, Cercignani, M, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Cupertino, RB, de Zeeuw, P, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fallgatter, AJ, Fair, DA, Faraone, SV, Frodl, T, Gabel, MC, Gogberashvili, T, Grevet, EH, Haavik, J, Harrison, NA, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Høvik, MF, Jahanshad, N, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lazaro, L, Lera-Miguel, S, Lesch, KP, Louza, MR, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Nicolau, R, Nigg, JT, O'Gorman Tuura, RL, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Picon, FA, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rosa, PGP, Rubia, K, Schrantee, A, Schweren, LJS, Seitz, J, Shaw, P, Silk, Tim, Skokauskas, N, Carlos Soliva Vila, J, Soloveva, A, Stevens, MC, Sudre, G, Tamm, L, Thompson, PM, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, Yoncheva, YN, Zanetti, MV, Ziegler, GC, Anikin, A, and Asherson, P

Published
2021

49. Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis

Author

Zhang-James, Y, Helminen, EC, Liu, J, Busatto, GF, Calvo, A, Cercignani, M, Chaim-Avancini, TM, Gabel, MC, Harrison, NA, Lazaro, L, Lera-Miguel, S, Louza, MR, Nicolau, R, Rosa, PGP, Schulte-Rutte, M, Zanetti, MV, Ambrosino, S, Asherson, P, Banaschewski, T, Baranov, A, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Bramati, IE, Brandeis, D, Brem, S, Buitelaar, JK, Castellanos, FX, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Dale, AM, de Zeeuw, P, Doyle, AE, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fair, DA, Fallgatter, AJ, Frodl, T, Gogberashvili, T, Haavik, J, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Hohmann, S, Høvik, MF, Jahanshad, N, Jernigan, TL, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lesch, KP, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Mehta, MA, Namazova-Baranova, L, Nigg, JT, Novotny, SE, O’Gorman Tuura, RL, Weiss, EO, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rubia, K, Schrantee, A, Schwarz, L, Schweren, LJS, Seitz, J, Shaw, P, Silk, Timothy, Skokauskas, N, Vila, JCS, Stevens, MC, Sudre, G, Tamm, L, Thompson, PM, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, Yoncheva, YN, Zhang-James, Y, Helminen, EC, Liu, J, Busatto, GF, Calvo, A, Cercignani, M, Chaim-Avancini, TM, Gabel, MC, Harrison, NA, Lazaro, L, Lera-Miguel, S, Louza, MR, Nicolau, R, Rosa, PGP, Schulte-Rutte, M, Zanetti, MV, Ambrosino, S, Asherson, P, Banaschewski, T, Baranov, A, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Bramati, IE, Brandeis, D, Brem, S, Buitelaar, JK, Castellanos, FX, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Dale, AM, de Zeeuw, P, Doyle, AE, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fair, DA, Fallgatter, AJ, Frodl, T, Gogberashvili, T, Haavik, J, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Hohmann, S, Høvik, MF, Jahanshad, N, Jernigan, TL, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lesch, KP, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Mehta, MA, Namazova-Baranova, L, Nigg, JT, Novotny, SE, O’Gorman Tuura, RL, Weiss, EO, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rubia, K, Schrantee, A, Schwarz, L, Schweren, LJS, Seitz, J, Shaw, P, Silk, Timothy, Skokauskas, N, Vila, JCS, Stevens, MC, Sudre, G, Tamm, L, Thompson, PM, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, and Yoncheva, YN

Published
2021

50. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

Author

Postema, MC, Hoogman, M, Ambrosino, S, Asherson, P, Banaschewski, T, Bandeira, CE, Baranov, A, Bau, CHD, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Brandeis, D, Brem, S, Buitelaar, JK, Busatto, GF, Castellanos, FX, Cercignani, M, Chaim-Avancini, TM, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Cupertino, RB, de Zeeuw, P, Doyle, AE, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fair, DA, Fallgatter, AJ, Faraone, SV, Frodl, T, Gabel, MC, Gogberashvili, T, Grevet, EH, Haavik, J, Harrison, NA, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Hohmann, S, Høvik, MF, Jernigan, TL, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lazaro, L, Lera-Miguel, S, Lesch, KP, Louza, MR, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Namazova-Baranova, L, Nicolau, R, Nigg, JT, Novotny, SE, Oberwelland Weiss, E, O'Gorman Tuura, RL, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Picon, FA, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rosa, PGP, Rubia, K, Schrantee, A, Schweren, LJS, Seitz, J, Shaw, P, Silk, Tim, Skokauskas, N, Soliva Vila, JC, Stevens, MC, Sudre, G, Tamm, L, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, Yoncheva, YN, Zanetti, MV, Ziegler, GC, Glahn, DC, Jahanshad, N, Postema, MC, Hoogman, M, Ambrosino, S, Asherson, P, Banaschewski, T, Bandeira, CE, Baranov, A, Bau, CHD, Baumeister, S, Baur-Streubel, R, Bellgrove, MA, Biederman, J, Bralten, J, Brandeis, D, Brem, S, Buitelaar, JK, Busatto, GF, Castellanos, FX, Cercignani, M, Chaim-Avancini, TM, Chantiluke, KC, Christakou, A, Coghill, D, Conzelmann, A, Cubillo, AI, Cupertino, RB, de Zeeuw, P, Doyle, AE, Durston, S, Earl, EA, Epstein, JN, Ethofer, T, Fair, DA, Fallgatter, AJ, Faraone, SV, Frodl, T, Gabel, MC, Gogberashvili, T, Grevet, EH, Haavik, J, Harrison, NA, Hartman, CA, Heslenfeld, DJ, Hoekstra, PJ, Hohmann, S, Høvik, MF, Jernigan, TL, Kardatzki, B, Karkashadze, G, Kelly, C, Kohls, G, Konrad, K, Kuntsi, J, Lazaro, L, Lera-Miguel, S, Lesch, KP, Louza, MR, Lundervold, AJ, Malpas, CB, Mattos, P, McCarthy, H, Namazova-Baranova, L, Nicolau, R, Nigg, JT, Novotny, SE, Oberwelland Weiss, E, O'Gorman Tuura, RL, Oosterlaan, J, Oranje, B, Paloyelis, Y, Pauli, P, Picon, FA, Plessen, KJ, Ramos-Quiroga, JA, Reif, A, Reneman, L, Rosa, PGP, Rubia, K, Schrantee, A, Schweren, LJS, Seitz, J, Shaw, P, Silk, Tim, Skokauskas, N, Soliva Vila, JC, Stevens, MC, Sudre, G, Tamm, L, Tovar-Moll, F, van Erp, TGM, Vance, A, Vilarroya, O, Vives-Gilabert, Y, von Polier, GG, Walitza, S, Yoncheva, YN, Zanetti, MV, Ziegler, GC, Glahn, DC, and Jahanshad, N

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results